A Physical Therapy Program Versus Surgery for Femoroacetabular Impingement: Randomized Clinical Trial
A Supervised Physical Therapy Program vs. Arthroscopic Surgery for Femoroacetabular Impingement: A Randomized Clinical Trial
1 other identifier
interventional
80
1 country
1
Brief Summary
The purpose of this study is to compare the outcomes for patients that receive two different treatments used for FAI (Femoroacetabular Impingement). The programs are 1) a 6-week supervised physical therapy program and 2) arthroscopic surgery. Enrollment is limited to patients that have already been determined surgical candidates. The study is following patients for a 2-year period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2013
CompletedFirst Submitted
Initial submission to the registry
October 30, 2013
CompletedFirst Posted
Study publicly available on registry
November 25, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2016
CompletedResults Posted
Study results publicly available
August 14, 2020
CompletedAugust 14, 2020
July 1, 2020
3.3 years
October 30, 2013
June 26, 2020
July 28, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Hip Outcome Score - ADL Subscale at 24 Months
The Hip Outcome Score is designed to assess higher-level activities (i.e. those required in athletics) and has demonstrated validity in a study of patients at a mean of three years following hip arthroscopy. Additionally, a 2011 study states that the HOS has the greatest amount of clinimetric evidence (rigor of rating scales and indexes for the description of clinical phenomena). Only three published patient-reported outcome instruments utilized to assess FAI and labral pathology use clinimetric evidence and the HOS was identified as the most proven instrument. The HOS ADL Subscale consisted of 19 questions, each scored on a 5-point scale from 0 (unable to do) to 4 (no difficulty). The final score is calculated by taking the raw score, dividing it by the number of total questions answered multipled by 4 x 100 for a final score that ranges from 0 to 100%, with lower scores associated with greater limitation in Activities of Daily Living (ADL).
24 months
Hip Outcome Score - Sport Subscale at 24 Months
The Hip Outcome Score is designed to assess higher level activities (i.e. those required in athletics) and has demonstrated validity in a study of patients at a mean of three years following hip arthroscopy. Additionally, a 2011 study states that the HOS has the greatest amount of clinimetric evidence (rigor of rating scales and indexes for the description of clinical phenomena). Only three published patient-reported outcome instruments utilized to assess FAI and labral pathology use clinimetric evidence and the HOS was identified as the most proven instrument. The HOS Sport Subscale consists of 9 questions, each scored on a 5-point scale from 0 (unable to do) to 4 (no difficulty). The final score is calculated by taking the raw score, dividing it by the number of total questions answered multipled by 4 x 100 for a final score that ranges from 0 to 100%, with lower scores associated with greater limitations in Sports-related activities.
24 months
Secondary Outcomes (2)
Group Differences in International Hip Outcome Score (IHOT33) to 24 Months
24 months
Global Rating of Change Score of 3+ or Higher (Minimum Clinically Important Change)
24 months
Other Outcomes (2)
Self-Motivation Inventory
Baseline
Changes From Baseline Pain Catastrophizing Scale at 24 Months
24 months
Study Arms (2)
Arthroscopic Surgery
ACTIVE COMPARATORArthroscopic surgery at the femoroacetabular joint, followed by a standardized post-operative rehabilitation protocol in physical therapy.
Physical Therapy
ACTIVE COMPARATORAn impairment-based supervised in-clinic physical therapy program.
Interventions
The hip arthroscopy will consist of acetabular rim trimming, labral repair or debridement and femoroplasty, all as indicated based on the surgeon's clinical judgment with input from pre-operative imaging, exam findings and intra-operative findings.
Subjects will participate in two 45-minute sessions for six weeks (total of 12 sessions). The physical therapy treatment plan will be based on individual impairments identified during the initial evaluation, and include manual therapy to the hip, lumbar spine, and pelvis, as well as therapeutic exercise all tailored to individual patient impairments.
Eligibility Criteria
You may qualify if:
- Tricare beneficiaries between the ages of 18 and 65
- Diagnosis of FAI and/or labral pathology confirmed by a combination of the following:
- Pain at the anterior hip or groin
- Pain with hip flexion
- Positive FADIR test
- Patient report relief of pain after intra-articular injection
- Surgical candidate for hip arthroscopy defined by (must have both):
- No less than 2 mm of joint space based on imaging (CT scan, radiographs and MR arthrogram)
- Positive crossover sign and/or alpha angle \>50 deg based on imaging (CT scan, radiographs and MR arthrogram)
- Failed 6 weeks of conservative management
You may not qualify if:
- Pregnancy
- Has other concurrent systemic disease that may affect the condition (cancer, rheumatoid arthritis, or other systemic arthralgia/arthritis)
- Has had surgery on the same hip that will be analyzed in the study
- Diagnosis of hip osteoarthritis is more likely
- Clearing the lumbar spine reproduces the patient's hip symptoms
- Plans to move/relocate out of the local area within 6 months
- Pending litigation for their hip condition
- Unable to give informed consent to participate in the study
- Unable to speak or read or write in English (due to inability to fill out outcome measures)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Madigan Army Medical Center
Tacoma, Washington, 98431, United States
Related Publications (2)
Mansell NS, Rhon DI, Meyer J, Slevin JM, Marchant BG. Arthroscopic Surgery or Physical Therapy for Patients With Femoroacetabular Impingement Syndrome: A Randomized Controlled Trial With 2-Year Follow-up. Am J Sports Med. 2018 May;46(6):1306-1314. doi: 10.1177/0363546517751912. Epub 2018 Feb 14.
PMID: 29443538DERIVEDMansell NS, Rhon DI, Marchant BG, Slevin JM, Meyer JL. Two-year outcomes after arthroscopic surgery compared to physical therapy for femoracetabular impingement: A protocol for a randomized clinical trial. BMC Musculoskelet Disord. 2016 Feb 4;17:60. doi: 10.1186/s12891-016-0914-1.
PMID: 26846934DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Daniel Rhon
- Organization
- Madigan Army Medical Center
Study Officials
- PRINCIPAL INVESTIGATOR
Nancy Mansell, PT, DPT
Madigan Army Medical Center
- STUDY CHAIR
Daniel Rhon, DPT, DSc
Madigan Army Medical Center
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Physical Therapy, Department of PM&R
Study Record Dates
First Submitted
October 30, 2013
First Posted
November 25, 2013
Study Start
March 1, 2013
Primary Completion
July 1, 2016
Study Completion
October 1, 2016
Last Updated
August 14, 2020
Results First Posted
August 14, 2020
Record last verified: 2020-07
Data Sharing
- IPD Sharing
- Will share
Any data sharing must go through a Data Sharing Agreement approved by the US Defense Health Agency